924367ab474f48ec820652.pdf



PRESS RELEASE

For immediate release


ASX ANNOUNCEMENT


JANGHO ACHIEVES COMPULSORY ACQUISITION THRESHOLD FOR VISION TAKEOVER OFFER



(Tuesday, 20 October 2015) - Jangho Group Co., Ltd. (Jangho) refers to the unconditional off- market takeover bid for all of the ordinary voting shares in Vision Eye Institute Limited (Offer and Vision respectively), made by Jangho's wholly owned Australian subsidiary, Jangho Health Care Australia Pty Ltd (Bidder).


The Bidder announces that acceptances of the Offers now exceed 90%. As at the time of this announcement, the voting power of the Bidder in Vision was approximately 90.95%.


Accordingly, the Bidder is entitled to compulsorily acquire of all of the outstanding ordinary voting shares in Vision. The Bidder expects to commence the compulsory acquisition process as soon as possible following completion of the transfer of Vision ordinary voting shares held by accepting shareholders under the Offer.


The offer period for the Offer will close as scheduled tomorrow at 7.00pm (Melbourne time) 21 October 2015. The Bidder will not extend the offer period.


How to Accept the Offer


To accept the Offer, complete the Acceptance Form that accompanied your copy of the Bidder's Statement in accordance with the instructions on it and return it by using the enclosed pre- addressed envelope so that it is received before the Offer closes. Alternatively, you may email a scanned copy of your completed Acceptance Form to Lisandra Rodrigues at Computershare (email: Lisandra.Rodrigues@computershare.com.au) with the original Acceptance Form to follow by post.


If your Vision Shares are held in CHESS (Holder Identification Number prefixed with 'X'), you can also accept the Offer by directly instructing your controlling participant (usually your stockbroker) to accept the Offer on your behalf.


You may only accept the Offer for all of your Vision Shares. Acceptances must be received before the Offer closes at 7.00pm (Melbourne time) on Wednesday, 21 October 2015.


If you have any questions about the Offer or require assistance with accepting the Offer please contact the Jangho Offer Information Line on 1300 374 107 (toll free within Australia) or +61 3 9415 4110 (not toll free) from outside Australia.


********************************

For media enquiries, please contact: Wang Peng

Company Secretary Jangho Group Co., Ltd

+86 (10)6041 1166 ext 8808


Email: wangpeng@jangho.com


About Jangho


Jangho is listed on the Main Board A of the Shanghai Stock Exchange (Stock Code: 601886). Jangho was established in 1999. Headquartered in Beijing, Jangho Group is a large-scale multinational enterprise of facade solutions which integrates R&D, engineering and design expertise, precision manufacturing, installation, consultancy, and product export for domestic and foreign markets. Jangho is in the top 500 Public Listed Enterprise and the top 500 Private Owned Enterprise in China. Jangho is actively participating in exploring new industries with focus on online business platforms, medical and health as well as PPP projects.


About Vision


Vision is Australia's largest provider of ophthalmic care, diagnosing and treating people with eye disorders and diseases. Vision provides services to doctor partners, associates, and visiting surgeons, offering a broad range of services including specialist eye care in the areas of corneal surgery, refractive surgery, cataract surgery, ocular plastics, glaucoma treatment and surgery, vitreo-retinal surgery, and treatment for macular degeneration. Vision is a public company listed on the Australian Securities Exchange (ASX Code: VEI).

****************************

distributed by